Search

Your search keyword '"A, Shotan"' showing total 32 results
Start Over Author "A, Shotan" Journal journal of cardiac failure
32 results on '"A, Shotan"'

3. Corrigendum to “Non-Invasive Lung Impedance-Guided Preemptive Treatment in Chronic Heart Failure Patients: A Randomized Controlled Trial (Impedance-HF Trial)”

Author

Shochat, Michael Kleiner, primary, Shotan, Avraham, additional, Blondheim, David S., additional, Kazatsker, Mark, additional, Dahan, Iris, additional, Asif, Aya, additional, Rozenman, Yoseph, additional, Kleiner, Ilia, additional, Weinstein, Jean Marc, additional, Frimerman, Aaron, additional, Vasilenko, Lubov, additional, and Meisel, Simcha R., additional

Published
2017
Full Text
View/download PDF

4. Non-Invasive Lung IMPEDANCE-Guided Preemptive Treatment in Chronic Heart Failure Patients: A Randomized Controlled Trial (IMPEDANCE-HF Trial)

Author

Aaron Frimerman, Simcha R. Meisel, Ilia Kleiner, Mark Kazatsker, Iris Dahan, Lubov Vasilenko, Yoseph Rozenman, Aya Asif, David S. Blondheim, Avraham Shotan, Jean Marc Weinstein, and Michael Shochat

Subjects
Male, medicine.medical_specialty, New York Heart Association Class, Pulmonary Edema, 030204 cardiovascular system & hematology, High-Density Lipoproteins, Pre-beta, law.invention, 03 medical and health sciences, 0302 clinical medicine, Randomized controlled trial, law, Reference Values, Internal medicine, Confidence Intervals, Electric Impedance, Medicine, Outpatient clinic, Humans, Single-Blind Method, 030212 general & internal medicine, Diuretics, Survival analysis, Aged, Heart Failure, Ejection fraction, business.industry, Stroke Volume, Stroke volume, Middle Aged, medicine.disease, Prognosis, Survival Analysis, Confidence interval, Respiratory Function Tests, Hospitalization, Treatment Outcome, Heart failure, Chronic Disease, Cardiology, Female, Cardiology and Cardiovascular Medicine, business
Abstract

Previous investigations have suggested that lung impedance (LI)-guided treatment reduces hospitalizations for acute heart failure (AHF). A single-blind 2-center trial was performed to evaluate this hypothesis (ClinicalTrials.gov-NCT01315223).The study population included 256 patients from 2 medical centers with chronic heart failure and left ventricular ejection fraction ≤35% in New York Heart Association class II-IV, who were admitted for AHF within 12 months before recruitment. Patients were randomized to a control group treated by clinical assessment and a monitored group whose therapy was also assisted by LI, and followed for at least 12 months. Noninvasive LI measurements were performed with a new high-sensitivity device. Patients, blinded to their assignment group, were scheduled for monthly visits in the outpatient clinics. The primary efficacy endpoint was AHF hospitalizations; the secondary endpoints were all-cause hospitalizations and mortality.There were 67 vs 158 AHF hospitalizations during the first year (P .001) and 211 vs 386 AHF hospitalizations (P .001) during the entire follow-up among the monitored patients (48 ± 32 months) and control patients (39 ± 26 months, P = .01), respectively. During the follow-up, there were 42 and 59 deaths (hazard ratio 0.52, 95% confidence interval 0.35-0.78, P = .002) with 13 and 31 of them resulting from heart failure (hazard ratio 0.30, 95% confidence interval 0.15-0.58 P .001) in the monitored and control groups, respectively. The incidence of noncardiovascular death was similar.Our results seem to validate the concept that LI-guided preemptive treatment of chronic heart failure patients reduces hospitalizations for AHF as well as the incidence of heart failure, cardiovascular, and all-cause mortality.

Published
2015

6. One Year Follow Up after Termination Non-Invasive Lung IMPEDANCE-Guided Preemptive Treatment in Chronic Heart Failure Patients: A Randomized Controlled Trial (IMPEDANCE-HF Trial)

Author

Iris Dahan, Ilia Kleiner, David S. Blondheim, Aya Asif, Avraham Shotan, Mark Kazatsker, Jean Marc Weinstein, Simcha Meisel, and Michael Shochat

Subjects
medicine.medical_specialty, One year follow up, business.industry, Non invasive, medicine.disease, Surgery, law.invention, Randomized controlled trial, law, Heart failure, medicine, Physical therapy, Cardiology and Cardiovascular Medicine, business, Lung impedance
Published
2016
Full Text
View/download PDF

10. Risk Assessment of Re-Hospitalizations for Heart Failure During 30 Days After Discharge for Acute Heart Failure

Author

Michael Shochat, Mark Kazatsker, Avraham Shotan, Aya Asif, Ilia Kleiner, David S. Blondheim, Iris Dahan, and Simcha Meisel

Subjects
medicine.medical_specialty, business.industry, Internal medicine, Heart failure, medicine, Cardiology, After discharge, Cardiology and Cardiovascular Medicine, business, Risk assessment, medicine.disease
Published
2015
Full Text
View/download PDF

26. Lung Impedance Guided Preemptive Treatment of Evolving Pulmonary Congestion-Edema in Course of Acute Myocardial Infarction Reduces Use of Furosemide

Author

Avraham Shotan, Mark Kazatsker, Michael Shochat, Yaniv Levy, David S. Blondheim, Iris Dahan, Simcha Meisel, and Aya Asif

Subjects
medicine.medical_specialty, business.industry, Furosemide, medicine.disease, Internal medicine, Edema, medicine, Cardiology, Myocardial infarction, Pulmonary congestion, medicine.symptom, Cardiology and Cardiovascular Medicine, business, Lung impedance, medicine.drug
Published
2012
Full Text
View/download PDF

27. Comparison of the Predictive Values of NT-proBNP and Lung Impedance Measurements in the Course of BNP-Guided Treatment of CHF Patients

Author

Ilia Shochat, Simcha Meisel, Yaniv Levy, Avraham Shotan, David S. Blondheim, Michael Shochat, Mark Kazatsker, Iris Dahan, and Aya Asif

Subjects
medicine.medical_specialty, business.industry, Internal medicine, Cardiology, medicine, Cardiology and Cardiovascular Medicine, business, Predictive value, Lung impedance
Published
2012
Full Text
View/download PDF

28. The Time Course of the Pulmonary Edema Development During ST Elevation Myocardial Infarction

Author

Mark Kazatsker, Simcha Meisel, Aya Asif, Ilia Shochat, Avraham Shotan, Michael Shochat, Yaniv Levy, David S. Blondheim, and Iris Dahan

Subjects
medicine.medical_specialty, business.industry, St elevation myocardial infarction, Internal medicine, Time course, Cardiology, Medicine, Cardiology and Cardiovascular Medicine, business, Pulmonary edema, medicine.disease
Published
2012
Full Text
View/download PDF

29. Importance of Lung Impedance Monitoring in the Outpatient Clinic for Predicting and Preventing of Hospitalizations Patients With Chronic Heart Failure

Author

Michael Shochat, Iris Dahan, David S. Blondheim, Simcha Meisel, Avraham Shotan, Elena Shochat, Aya Asif, Yaniv Levy, and Mark Kazatsker

Subjects
medicine.medical_specialty, business.industry, Heart failure, Medicine, Outpatient clinic, Cardiology and Cardiovascular Medicine, business, medicine.disease, Intensive care medicine, Lung impedance
Published
2012
Full Text
View/download PDF

31. Short and Long-Term Outcome of Impedance-Guided Preemptive Therapy Provided To Prevent Acute Heart Failure in the Course of Acute Myocardial Infarction

Author

Simcha R. Meisel, Michael Shochat, Aya Asif, Iris Dahan, David Blomdhaim, Avraham Shotan, and Ilia Shochat

Subjects
medicine.medical_specialty, business.industry, Internal medicine, Heart failure, medicine, Cardiology, Electrocardiography in myocardial infarction, Myocardial infarction, Cardiology and Cardiovascular Medicine, business, medicine.disease, Outcome (game theory), Term (time)
Published
2011
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results